Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.65
Bid: 1.60
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.10 (6.25%)
Open: 1.65
High: 1.65
Low: 1.65
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

Mon, 20th Mar 2023 09:37

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Directa Plus PLC, up 4.8% at 87.00 pence, 12-month range 66.25p - 135.00p. The London-based graphene product maker says one of its graphene technologies was awarded a European patent. The company's G+ graphene technology is granted an Italian patent for air filtering applications. These include automotive applications, as well as heating ventilation and air conditioning. Its intellectual portfolio now is comprised of 22 patent families, with 81 granted patents, and a further 36 pending.

----------

Genedrive PLC, up 1.7% at 43.72 pence, 12-month range 8.00p - 48.86p. The Manchester-based molecular diagnostics company announces that that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester. Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

----------

AIM - LOSERS

----------

Tribal Group PLC, down 12% at 43.85 pence, 12-month range 37.00p - 96.00p. The Bristol-based educational software and services provider reports that Singapore's Nanyang Technological University has decided to terminate its contract with the company and has also reserved rights to claim damages. Tribal says it rejects NTU's right to terminate and is considering its options regarding the next appropriate steps. Consequently, the company revises the publication date of its annual results to March 24 to allow it time to consider the impact of the contract termination, particularly the accounting treatment of a GBP4.5 million onerous contract provision contained within previous expectations. Tribal has an eight-year contract with NTU for the delivery of Tribal's cloud-based SITS:Vision Student Management System and its Tribal Edge solutions. The contract was originally announced back in April 2021. In February, the company said significant delays in its Singapore contract hurt its overall trading in 2022.

----------

Jubilee Metals Group PLC, down 5.8% at 7.45 pence, 12-month range 7.30p - 17.50p. The London-based metal processing company says interim profit more than halved as the metal processing company grappled with power outages in South Africa and poor infrastructure in Zambia. Reports a 54% decline in pretax profit to GBP4.3 million for the six months that ended December 31 from GBP9.3 million a year earlier. Revenue dips to GBP63.1 million from GBP63.3 million. Platinum group metals operations record 18,208 ounces, all from own operations, down from 20,316 ounces. Records copper production of 1,149 tonnes compared to 1,314 tonnes and below expectation as a consequence of the delayed ramp-up of the Roan concentrator, mainly due to power and water disruptions in Zambia.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 May 2024 12:10

IN BRIEF: Genedrive completes placing portion of GBP6 million raise

Genedrive PLC - Manchester-based pharmacogenetic testing - Completes placing of 138.8 million new shares at 1.5 pence each, raising GBP2.1 million. The placing is part of an overall equity raise being run by Peel Hunt LLP. Late Thursday, Genedrive had said it will try to raise a minimum of GBP6.0 million, including offers to retail investors. If that minimum is not reached, then only the firm placing will go ahead. The placing and retail offer prices will be the same and represent a more than 50% discount to Genedrive's closing price on Thursday. The placing shares will almost double Genedrive's total, and the retail offers could see another 376.4 million new shares issued. It expects to call a general meeting for May 31 to approve the share issue.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
10 May 2024 07:00

IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer

Genedrive PLC - Manchester-based pharmacogenetic testing company - Seeks to raise a minimum of GBP6.0 million from an offer of new shares at 1.5 pence each. The announcement is made after the London market close on Thursday, and the price represents a more than 50% discount to Genedrive's closing price. The equity raise will be split into a firm placing of shares for GBP2.5 million, an offer to new and existing retail investors via the REX platform for GBP3.5 million, and an open offer to existing shareholders for GBP2.1 million. Genedrive says that if the GBP6.0 million minimum target is not reached, then only the firm placing will go ahead. The share sale is being run by broker Peel Hunt LLP.

Read more
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
28 Mar 2024 14:35

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2024 14:27

Genedrive receives R&D tax credit, plans fundraise

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Read more
15 Mar 2024 13:50

Genedrive down as plans equity raise despite GBP800,000 tax credit

(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.

Read more
19 Feb 2024 18:57

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
19 Feb 2024 10:56

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
2 Jan 2024 14:39

Genedrive confirms £0.6m equity prepayment drawdown

(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.